paperKB
coga / coga-kb
Help
Sign in

Chunk #9 — METHODS — UNIVERSITY OF WISCONSIN TRANSDISCIPLINARY TOBACCO USE RESEARCH CENTER (UW-TTURC)

Source
Interplay of genetic risk factors (CHRNA5-CHRNA3-CHRNB4) and cessation treatments in smoking cessation success.
Embedded
yes

Text

Participants (N=1,073) were randomly assigned to one of six conditions: placebo (n = 132), nicotine patch (n = 187); nicotine lozenge (n = 183); bupropion SR (n = 188); nicotine patch and nicotine lozenge (n = 193); or bupropion and nicotine lozenge (n = 190). All participants received six brief (10 minute) individual counseling sessions.